Thermo Fisher Scientific Inc. (BIT:1TMO)
Italy · Delayed Price · Currency is EUR | Market Cap | 187.87B +20.2% |
| Revenue (ttm) | 40.63B +7.2% |
| Net Income | 6.11B +5.8% |
| EPS | 16.29 +7.4% |
| Shares Out | n/a |
| PE Ratio | 30.75 |
| Forward PE | 22.29 |
| Dividend | 1.55 (0.30%) |
| Ex-Dividend Date | Jun 12, 2026 |
| Volume | 3 |
| Open | 516.80 |
| Previous Close | 521.40 |
| Day's Range | 510.20 - 516.80 |
| 52-Week Range | 374.30 - 545.10 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analy... [Read more]
Financial Performance
In 2025, Thermo Fisher Scientific's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.
Financial numbers in USD Financial StatementsNews
Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist
LUXEMBOURG & NEW YORK & PARIS--(BUSINESS WIRE)--Astorg, a leading pan-European private equity firm, today announced the successful completion of its acquisition of the global microbiology business fro...
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has completed the sale of its microbiology business to Astorg, ...
Thermo Fisher eyes 15%-20% India customer growth on biopharma research, manufacturing boost
Thermo Fisher Scientific is eyeing a 15%-20% increase in its customer base in India over the next five years, betting on the growing biopharma research and manufacturing ecosystem, the head of its I...
Thermo Fisher Scientific Presents End-to-End Diagnostic and Lab Solutions Addressing Unmet Clinical Needs at ADLM 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase its latest diagnostic innovations, recent regulatory milestones and expanded capabilities ...
Thermo Fisher Scientific Launches Thermo Scientific™ InstaFlux™ to Help Food Microbiology Labs Simplify Workflows in Pathogen and Environmental Testing
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the global launch of Thermo Scientific™ InstaFlux™, an integrated media-on-demand enrichment workflow that helps food microbio...
Thermo Fisher Scientific Earnings Call Transcript: Q2 2026
Q2 delivered double-digit revenue and EPS growth, with strong performance across all segments and geographies. Full-year guidance was raised for both revenue and EPS, reflecting robust customer activity, successful acquisitions, and continued innovation.
Thermo Fisher Scientific Earnings release: Q2 2026
Thermo Fisher Scientific released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
Thermo Fisher Scientific Quarterly report: Q2 2026
Thermo Fisher Scientific has published its Q2 2026 quarterly earnings report on July 23, 2026.
Thermo Fisher beats quarterly estimates as customer demand improves
Thermo Fisher Scientific beat Wall Street estimates for second-quarter profit and revenue on Thursday, as improving customer demand lifted sales across all its business segments.
Thermo Fisher Scientific Reports Second Quarter 2026 Results
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 27, 2026. Second...
Thermo Fisher Scientific Announces Quarterly Dividend
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its Board of Directors authorized a quarterly cash dividend of $0....
Thermo Fisher Scientific Receives First FBI Approval for Rapid DNA Crime Scene Profiles Eligible for National CODIS Searches
SAN FRANCISCO--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced that the Applied Biosystems™ RapidINTEL™ Plus Cartridge has received approval from the Fe...
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2026 before...
Thermo Fisher Scientific Showcases New Capabilities Across Manufacturing, Clinical Development and AI-Enabled Research at BIO International 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, will showcase new capabilities, strategic investments and initiatives at BIO International 2026 that are...
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today expanded its suite of Thermo Scientific™ Orbitrap™ mass spectrometry platforms, AI-enabled so...
Thermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate the Path from Drug Discovery to New Therapies
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the Thermo Scientific™ Orbitrap™ Tribrid™ Apex and Thermo Scientific™ O...
Thermo Fisher Scientific Transcript: AGM 2026
Shareholders elected all director nominees and ratified the auditor, but did not approve executive compensation. The company reported strong financials, highlighted its global reach, and outlined strategic priorities including AI adoption and continued productivity improvements.
Thermo Fisher Scientific Slides: FY 2026
Thermo Fisher Scientific has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 20, 2026.
Thermo Fisher Scientific Transcript: Investor Day 2026
Positioned as an industry leader, the company targets 7% long-term organic revenue CAGR, driven by innovation, AI adoption, and disciplined capital deployment. Recent acquisitions and a robust commercial engine support share gains, with 2026 guidance of 3%–4% organic growth and 8%–10% EPS growth.
Thermo Fisher Scientific Slides: FY 2026
Thermo Fisher Scientific has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 20, 2026.
Thermo Fisher Scientific Highlights Industry Leadership, Growth Outlook and Long-Term Value Creation at 2026 Investor Day
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, hosted its Investor Day today. Chairman and Chief Executive Officer Marc N. Casper and ...
Thermo Fisher Scientific's PPD Clinical Research Business Expands Bioanalytical Capabilities with New Laboratory in Gothenburg, Sweden
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced the opening of a new bioanalytical and biomarker laboratory in Gothenburg, Sweden, locat...
Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle
ROCHESTER, N.Y.--(BUSINESS WIRE)--Nalgene Outdoor today introduces the Fresh Flow™ straw bottle, a new addition to its reusable bottle collection designed to give fans more ways to hydrate without sac...
Thermo Fisher Scientific Proxy statement: Proxy filing
Thermo Fisher Scientific filed a proxy statement on May 11, 2026, providing details for shareholder voting and corporate governance matters.
Thermo Fisher Scientific's Clinical Research Business Named a Leader Among CROs in 2026 ISG Provider Lens™ Report for Use of AI in Clinical Trials
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, earned a Leader designation among contract research organizations (CROs) in the 2026 ISG Provider L...